Von Willebrand disease: Pathogenesis and management

详细信息    查看全文

• 作者：Francesco Rodeghiero ; ^{rodeghiero@hemato.ven.it}
• 关键词：Inherited bleeding disorders ; Von Willebrand factor ; Von Willebrand disease ; Desmopressin ; Factor VIII/von Willebrand factor concentrates
• 刊名：Thrombosis Research
• 出版年：2013
• 出版时间：January, 2013
• 年：2013
• 卷：131
• 期：supp_S1
• 页码：S47-S50
• 全文大小：199 K

文摘

Recent studies have suggested a unifying pathophysiological concept to explain the underlying defects of von Willebrand factor (VWF) causing von Willebrand disease (VWD) and have highlighted the relevance of simple VWF related activities in producing a useful diagnosis. A standardized bleeding history condensed into a final bleeding score and few widely available laboratory tests, such as VWF ristocetin cofactor activity, VWF antigen and factor VIII (FVIII), in the index case and in his/her relatives are of critical importance. Ristocetininduced platelet aggregation (RIPA) should also be tested. Trial with desmopressin should be carried out in patients, except those with virtual absence of VWF or with increased RIPA. Desmopressin should be used in all responsive patients as first choice. Substitutive treatment with VWF/FVIII containing products should be used in unresponsive patients, in those with heightened response to desmopressin or in those undergoing interventions requiring good hemostasis for more than 3-5 days. Special consideration should be deserved to the treatment of menorrhagia and parturition.